Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,054 | 83,951 | 116,153 | 105,089 | 43,583 |
| Marketable Securities | 82,492 | 31,523 | 29,516 | 24,063 | 55,278 |
| Receivables | 28,936 | 26,961 | 23,722 | 24,065 | 19,412 |
| Inventories | 41,046 | 38,395 | 39,077 | 37,394 | 28,502 |
| TOTAL | $191,621 | $186,573 | $213,178 | $196,278 | $152,273 |
| Non-Current Assets | |||||
| PPE Net | 20,072 | 17,873 | 17,757 | 17,608 | 16,556 |
| Investments And Advances | 98,197 | 93,596 | 56,344 | 40,536 | 33,450 |
| Intangibles | 79,118 | 73,636 | 73,546 | 73,349 | 45,164 |
| Other Non-Current Assets | 23,518 | 30,851 | 31,708 | 28,984 | 27,225 |
| TOTAL | $220,905 | $215,956 | $179,355 | $160,477 | $122,395 |
| Total Assets | $412,526 | $402,529 | $392,533 | $356,755 | $274,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,947 | 6,604 | 4,621 | 4,313 | 3,764 |
| Accrued Expenses | 11,897 | 11,561 | 13,381 | 11,009 | 10,249 |
| Other current liabilities | N/A | 10,429 | 10,373 | 9,183 | 7,908 |
| TOTAL | $20,618 | $32,443 | $29,539 | $25,451 | $21,921 |
| Non-Current Liabilities | |||||
| Long Term Debt | 119,257 | 119,911 | 119,653 | 104,681 | N/A |
| Deferred Revenues | N/A | 3,317 | 963 | 946 | N/A |
| Other Non-Current Liabilities | 3,703 | 2,714 | 2,247 | 2,123 | 1,887 |
| TOTAL | $123,378 | $123,031 | $124,907 | $109,892 | $5,150 |
| Total Liabilities | $143,996 | $155,474 | $154,446 | $135,343 | $27,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,926 | 54,298 | 53,428 | 52,123 | 54,652 |
| Common Shares | 286 | 276 | 276 | 276 | 272 |
| Retained earnings | -17,462 | -26,634 | -33,467 | -38,885 | -44,323 |
| Other shareholders' equity | 3,990 | 2,319 | 2,067 | 830 | 1,641 |
| TOTAL | $268,530 | $247,055 | $238,087 | $221,412 | $247,597 |
| Total Liabilities And Equity | $412,526 | $402,529 | $392,533 | $356,755 | $274,668 |